Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products Expenditure

Dáil Éireann Debate, Wednesday - 26 September 2012

Wednesday, 26 September 2012

Ceisteanna (204)

Richard Boyd Barrett

Ceist:

204. Deputy Richard Boyd Barrett asked the Minister for Health if he will report on the progress made of receiving price reductions on generic drugs; and if he will make a statement on the matter. [41013/12]

Amharc ar fhreagra

Freagraí scríofa

Negotiations are ongoing between officials of my Department/HSE and the Association of Pharmaceutical Manufacturers in Ireland (APMI) regarding a new agreement on the price of generic medical products. It is hoped that these negotiations will conclude shortly and provide for additional savings in the cost of generic medicines.

The Health (Pricing and Supply of Medical Goods) Bill 2012 was published on the 13th of July 2012. This legislation will introduce a system of reference pricing and generic substitution for prescribed drugs and medicines. These reforms will promote price competition among suppliers and ensure that lower prices are paid for these medicines resulting in savings for taxpayers and patients.

Barr
Roinn